Talzenna 1mg (Talazoparib Capsule) 1mg

Talzenna 1mg (talazoparib) capsules are a prescription PARP inhibitor used in targeted cancer therapy. This oral medication is designed for adult patients managing specific types of cancer. Talzenna 1mg supports treatment plans by targeting cancer cells with precision. Ideal for convenient at-home administration.

Strength

1mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Pfizer

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Talzenna 1mg (talazoparib) is prescribed for adults with certain types of cancer, including breast cancer, to help slow disease progression. It is used when cancer has specific genetic markers, such as BRCA mutations. This medication is part of a broader treatment strategy to manage advanced cancer. It is not suitable for all cancer types or patient profiles.

Side Effects

Talzenna 1mg capsules are taken orally and may cause fatigue, nausea, or decreased appetite in some users. Some patients report mild digestive discomfort or headaches during treatment. These effects vary by individual and are typically monitored by a healthcare provider. Regular follow-ups help assess ongoing tolerance.

Precautions & Warnings

Store Talzenna 1mg capsules at room temperature, away from moisture and direct light. Keep out of reach of children and pets. Do not open or crush capsules unless directed by a healthcare professional. Inform your doctor about all medications and supplements you are taking before starting this treatment.

Avoid Interactions

Talzenna 1mg may interact with strong CYP3A inhibitors or inducers, which can alter its effectiveness. Grapefruit products should be avoided due to potential interaction risks. Alcohol use should be discussed with a healthcare provider, as it may affect treatment tolerance. Always review your full medication list with your doctor.

Frequently Asked Questions

Talzenna 1mg is used to treat certain types of cancer in adults, such as breast cancer with specific genetic markers.

Store Talzenna 1mg capsules at room temperature, away from moisture and direct light.

Always consult your healthcare provider before combining Talzenna 1mg with other medications or supplements.

Common side effects may include fatigue, nausea, or decreased appetite. These vary by individual.

Talzenna 1mg is a targeted therapy, not a traditional chemotherapy agent.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.